Even though we did not differentiate patients according their MYCN status in order to calculate their survival rate independently, our Kaplan-Meier analysis revealed that patients with high Oct4+ cell percentage tumours were not only more prone to suffer from tumour relapse, but also had a higher death hazard. This evidence concerns the gene POU5F1 and neoplasm.